C4 THERAPEUTICS INC. - COMMON STOCK
4.4450
08-July-24 12:12:41
15 minutes delayed
Stocks
-0.0750
-1.66%
Today's range
4.4300 - 4.6900
ISIN
N/A
Source
NASDAQ
-
C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day
08 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
10 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
08 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
29 Apr 2024 16:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
09 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
04 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
09 Jan 2024 16:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
04 Jan 2024 16:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
12 Dec 2023 16:01:00 By Nasdaq GlobeNewswire
-
12 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
28 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
20 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
01 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
11 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Chief Financial Officer Succession
05 Sep 2023 16:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
08 Aug 2023 07:00:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >